TIDMAMS
RNS Number : 0299R
Advanced Medical Solutions Grp PLC
11 June 2018
11 June 2018
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Director/PDMR Shareholding
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS),
the surgical and advanced wound care specialist company, announces
that it was notified on 6 June 2018 that Pieter van Hoof, who is a
Senior Manager and PDMR, following the successful achievement of
certain performance criteria, has exercised 36,375 options from the
Long Term Incentive Plan (LTIP). Mr van Hoof has also, following
the end of the holding period, exercised 4,643 options from the
Deferred Annual Bonus Plan (DAB). Mr van Hoof elected to receive an
additional 58 dividend shares which were earned during the 3 year
holding period under the terms of the scheme. Mr van Hoof has also
elected to exercise 13,608 Ordinary Shares of 5p from the Deferred
Share Bonus Plan.
Mr van Hoof subsequently sold 61,488 Ordinary Shares of 5p each
on 6 June 2018 at a share price of 330.50p per Ordinary Share. As a
result of these transactions Pieter van Hoof's beneficial interest
in the Company has decreased from 127,208 shares to 120,404
shares.
Long Term Incentive Plan (LTIP)
PDMR No. of LTIPs Ordinary Ordinary LTIPs
LTIPs prior exercised Shares Shares after
to exercise sold retained exercise
------------ ------------- ----------- --------- ---------- ----------
Pieter van
Hoof 108,300 36,375 36,375 Nil 71,925
------------ ------------- ----------- --------- ---------- ----------
Deferred Annual Bonus Plan (DAB)
PDMR DABs DABs Dividend Ordinary Ordinary DABs
prior exercised Shares Shares Shares after
to exercise received sold retained exercise
------------ ------------- ----------- ---------- --------- ---------- ----------
Pieter van
Hoof 18,809 4,643 58 4,701 Nil 14,166
------------ ------------- ----------- ---------- --------- ---------- ----------
Deferred Share Bonus Plan (DSB)
PDMR No. of DSBs DSBs exercised Ordinary Ordinary DSBs after
prior to Shares Shares exercise
exercise sold retained
------------ ------------ --------------- --------- ---------- -----------
Pieter van
Hoof 28,818 13,608 13,608 Nil 15,210
------------ ------------ --------------- --------- ---------- -----------
Overall Holding
PDMR Holding Number Dividend Number Sale Resultant % of
prior of shares Shares of shares price holding issued
to exercise exercised received sold (p) share
capital
------------ ------------- ----------- ---------- ----------- -------- ---------- ---------
Pieter van
Hoof 127,208 54,626 58 61,488 330.50p 120,404 0.056%
------------ ------------- ----------- ---------- ----------- -------- ---------- ---------
The Company further announces that it was notified on 6 June
2018 that Simon Coates, who is a Senior Manager and PDMR, elected
to exercise 9,518 Ordinary Shares of 5p from the Deferred Share
Bonus Plan (DSB). Mr Coates subsequently sold 4,490 Ordinary Shares
of 5p each on 6 June 2018 at a share price of 330.50p per Ordinary
Share to cover the tax and National Insurance payable on this
exercise. As a result of these transactions Simon Coates's
beneficial interest in the Company has increased from 97,581 shares
to 102,609 shares.
Deferred Share Bonus Plan (DSB)
PDMR No. of DSBs DSBs exercised Ordinary Ordinary DSBs after
prior to Shares Shares exercise
exercise sold retained
-------------- ------------ --------------- --------- ---------- -----------
Simon Coates 39,736 9,518 4,490 Nil 30,218
-------------- ------------ --------------- --------- ---------- -----------
Overall Holding
PDMR Holding Number Number Number Sale Resultant % of
prior of shares of shares of shares price holding issued
to exercise exercised sold retained (p) share
capital
-------------- ------------- ----------- ----------- ----------- -------- ---------- ---------
Simon Coates 97,581 9,518 4,490 5,028 330.50p 102,609 0.048%
-------------- ------------- ----------- ----------- ----------- -------- ---------- ---------
The Company further announces that it was notified on 8 June
2018 that Steve Bellamy, who is a Director and PDMR, transferred
the legal ownership of his shares from ADM Investors Nominees
Limited to HSBC Global Custody Nominee (UK) Limited. The number of
shares held by Steve Bellamy and the beneficial ownership of the
shares remains unchanged.
Overall Holding
PDMR Holding Number Sale Resultant % of issued
prior of shares price holding share capital
to exercise sold (p)
--------------- ------------- ----------- ------- ---------- ---------------
Steve Bellamy 100,000 Nil - 100,000 0.047%
--------------- ------------- ----------- ------- ---------- ---------------
The notification below, made in accordance with the requirements
of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1. Details of the person discharging managerial
responsibilities/person closely associated
--- ---------------------------------------------------------------
a) Name: Pieter van Hoof
--- ---------------------------------------------------------------
2. Reason for the notification
--- ---------------------------------------------------------------
a) Position/status: Senior Manager/PDMR
--- ---------------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- ---------------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ---------------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- ---------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- ---------------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ---------------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- ---------------------------------------------------------------
b) Nature of the transactions:
* Exercise of 36,375 shares from the Long Term
Incentive Plan
* Exercise of 4,643 shares from the Deferred Annual
Bonus Plan
* Award of 58 Dividend Shares from the Deferred Annual
Bonus Plan
* Exercise of 13,608 shares from the Deferred Share
Bonus Plan
* Sale of 61,488 Ordinary Shares of 5p
--- ---------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
---------- ----------
GBP3.305 61,488
---------- ----------
--- ---------------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: 61,488
Aggregated price: GBP3.305
--- ---------------------------------------------------------------
e) Date of the transaction: 06/06/2018
--- ---------------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- ---------------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- -----------------------------------------------------------
a) Name: Simon Coates
--- -----------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------
a) Position/status: Senior Manager/PDMR
--- -----------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- -----------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- -----------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- -----------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- -----------------------------------------------------------
b) Nature of the transactions:
* Exercise of 9,518 shares from the Deferred Share
Bonus Plan
* Sale of 4,490 Ordinary Shares of 5p
--- -----------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
---------- ----------
GBP3.305 4,490
---------- ----------
--- -----------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: 4,490
Aggregated price: GBP3.305
--- -----------------------------------------------------------
e) Date of the transaction: 06/06/2018
--- -----------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- -----------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- ----------------------------------------------------------
a) Name: Steve Bellamy
--- ----------------------------------------------------------
2. Reason for the notification
--- ----------------------------------------------------------
a) Position/status: Director/PDMR
--- ----------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- ----------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ----------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- ----------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- ----------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ----------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- ----------------------------------------------------------
b) Nature of the transactions:
* Transfer of legal ownership of 100,000 Ordinary
Shares of 5p
--- ----------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares:
Nil
--- ----------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: Nil
Aggregated price: Nil
--- ----------------------------------------------------------
e) Date of the transaction: 08/06/2018
--- ----------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- ----------------------------------------------------------
-End -
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group Tel: +44 (0)
plc 1606 545508
Chris Meredith, Chief Executive
Officer
Mary Tavener, Chief Financial
Officer
Consilium Strategic Communications Tel: +44 (0)
20 3709 5700
Mary-Jane Elliott / Matthew Neal AMS@consilium-comms.com
/ Nicholas Brown
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0)
20 7597 5970
Daniel Adams / Patrick Robb /
Gary Clarence
About Advanced Medical Solutions Group plc - see
www.admedsol.com
AMS is a world-leading independent developer and manufacturer of
innovative and technologically advanced products for the global
surgical, wound care and wound closure markets, focused on quality
outcomes for patients and value for payors. AMS has a wide range of
products that include silver alginates, alginates, foams, tissue
adhesives, sutures and haemostats, which it markets under its
brands; ActivHeal(R), LiquiBand(R) and RESORBA(R) as well as
supplying under white label.
AMS's products, manufactured out of two sites in the UK, one in
the Netherlands, two in Germany and one in the Czech Republic, are
sold in more than 75 countries via a network of multinational or
regional partners and distributors, as well as via AMS's own direct
sales forces in the UK, Germany, the Czech Republic and Russia.
Established in 1991, the Group has approximately 600 employees. For
more information, please see www.admedsol.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHBLGDLIGBBGIB
(END) Dow Jones Newswires
June 11, 2018 12:12 ET (16:12 GMT)
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2024 to May 2024
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From May 2023 to May 2024